Opportunity Information: Apply for W81XWH 21 CPMRP CEA
The Department of Defense Chronic Pain Management, Clinical Exploration Award (FY21 CPMRP CEA; Funding Opportunity Number W81XWH 21 CPMRP CEA) is a research funding opportunity run through the Department of Defense, Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA). It is designed to push chronic pain care forward by funding early, clinically oriented studies that can quickly test promising ideas and remove real-world clinical barriers that currently limit effective pain management. The program emphasizes projects that are grounded in a clear, testable hypothesis and that can plausibly create a meaningful shift in how chronic pain is treated, rather than incremental work that only confirms what is already known.
At its core, the award supports proof-of-principle pilot studies, clinical trials, and correlative studies. In practical terms, that means applicants can propose smaller-scale studies that establish feasibility and early signals of benefit, more formal clinical trials that evaluate an intervention in people, and studies that connect clinical outcomes with biological, behavioral, or other measurable markers to help explain why an intervention works and for whom. The expectation is that these funded projects will produce strong scientific and clinical rationale for later, larger clinical trials, ultimately helping move the field toward interventions that can transform routine clinical care.
A defining feature of this opportunity is its focus on innovative, "outside-the-box" approaches. The DoD is looking for novel clinical concepts and creative avenues of investigation aimed at chronic pain management, especially where current practice falls short. Importantly, "novel" does not necessarily mean the therapy has never existed before; the program allows investigators to repurpose therapies that are already in clinical use or being tested for other conditions, as long as the proposed application to chronic pain would represent a major advancement in patient care. Applicants are expected to clearly explain what clinical knowledge gap their study addresses, why that gap matters for patients and providers, and how the results would set up the next steps toward changing clinical practice.
The opportunity also draws a clear boundary around opioid-related proposals. Projects that seek to develop new opioid-based therapeutic interventions are not aligned with the intent of this mechanism and may be withdrawn. However, studies that aim to understand, optimize, and reduce opioid utilization within the realities of current prescribing practices are considered acceptable. In other words, the program is open to research that helps clinicians and systems move toward safer, more effective chronic pain management with less reliance on opioids, but it is not meant to expand opioid therapeutic options.
From an administrative standpoint, the award is offered as either a grant or a cooperative agreement under the Science and Technology and other Research and Development category (CFDA 12.420). Eligibility is listed as unrestricted, meaning the competition is open to a broad range of applicant organizations, subject to any additional eligibility clarifications in the full announcement. The opportunity was posted June 15, 2021, with an original closing date of November 12, 2021, and it anticipated making about four awards. The listed award ceiling is shown as 0 in the source data, which typically indicates that the specific maximum budget may be defined elsewhere in the full funding announcement or handled through programmatic/budget negotiation rather than a single fixed cap.
Overall, this award mechanism is best understood as a launchpad for clinically relevant, hypothesis-driven innovation in chronic pain management: fund a well-justified early clinical study now, produce convincing evidence and mechanistic or correlative insight, and then use those results to support larger trials and, ultimately, changes in patient care.Apply for W81XWH 21 CPMRP CEA
- The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DOD Chronic Pain Management, Clinical Exploration Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
- This funding opportunity was created on Jun 15, 2021.
- Applicants must submit their applications by Nov 12, 2021. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 4 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: DoD Chronic Pain Management, Clinical Exploration Award (FY21 CPMRP CEA)
What is the DoD Chronic Pain Management, Clinical Exploration Award (FY21 CPMRP CEA)?
The FY21 CPMRP Clinical Exploration Award (CEA) is a Department of Defense research funding opportunity intended to accelerate clinically relevant innovation in chronic pain management. It supports early-stage, clinically oriented studies that can quickly test promising ideas and address practical barriers that limit effective pain care in real-world settings.
Which agency runs this funding opportunity?
The opportunity is run through the Department of Defense, Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA).
What is the Funding Opportunity Number for this award?
The Funding Opportunity Number is W81XWH 21 CPMRP CEA.
What is the main goal of this award mechanism?
The main goal is to push chronic pain care forward by funding hypothesis-driven, clinically focused studies that can plausibly lead to meaningful shifts in how chronic pain is treated. The emphasis is on generating strong scientific and clinical rationale for later, larger clinical trials and ultimately supporting changes in routine clinical care.
What kinds of studies does the program support?
The award supports proof-of-principle pilot studies, clinical trials, and correlative studies. These can include smaller-scale feasibility and early-signal studies, more formal clinical trials evaluating interventions in people, and studies that link clinical outcomes to measurable markers (biological, behavioral, or other) to help explain how an intervention works and who benefits.
What does "proof-of-principle" mean in this context?
In this context, proof-of-principle refers to early studies designed to establish feasibility and provide initial evidence that an approach may be beneficial. The intent is to produce results that justify and inform subsequent, larger clinical trials.
Are clinical trials allowed under this opportunity?
Yes. Clinical trials are explicitly included among the supported study types, as long as they align with the program's clinically oriented, hypothesis-driven intent and focus on advancing chronic pain management.
What are "correlative studies" and why are they included?
Correlative studies are studies that connect clinical outcomes with measurable markers (for example, biological or behavioral measures) to help explain why an intervention works and for whom. They are included to strengthen clinical and scientific rationale and to support the design and justification of future, larger trials.
How does the program define "innovative" or "outside-the-box" approaches?
The program is looking for novel clinical concepts and creative avenues of investigation aimed at improving chronic pain management, particularly where current practice is limited. "Novel" does not require that a therapy has never existed; repurposing therapies already in clinical use or being tested for other conditions can be considered innovative if the application to chronic pain would represent a major advancement in patient care.
Does the award prefer major advances over incremental research?
Yes. The opportunity emphasizes projects that can plausibly create a meaningful shift in chronic pain treatment rather than incremental work that primarily confirms what is already known.
What is expected regarding hypothesis and study rationale?
Projects are expected to be grounded in a clear, testable hypothesis. Applicants are also expected to explain the clinical knowledge gap being addressed, why it matters for patients and providers, and how the results would set up next steps toward changing clinical practice.
Can applicants propose repurposing existing therapies for chronic pain?
Yes. Repurposing therapies already in clinical use or being tested for other conditions is allowed, as long as the proposed use in chronic pain would be a major advancement and the proposal clearly explains the clinical gap and potential impact.
Are opioid-related projects allowed?
The opportunity draws a clear boundary: projects that seek to develop new opioid-based therapeutic interventions are not aligned with the intent of this mechanism and may be withdrawn. However, studies that aim to understand, optimize, and reduce opioid utilization within current prescribing realities are considered acceptable.
What does it mean that some opioid proposals "may be withdrawn"?
Based on the opportunity description, proposals focused on developing new opioid-based therapeutic interventions are considered misaligned with program intent and may be removed from consideration. The program, however, remains open to research intended to reduce reliance on opioids and improve safety and effectiveness in chronic pain care.
What type of award instrument is used (grant or cooperative agreement)?
This opportunity may be offered as either a grant or a cooperative agreement, under the Science and Technology and other Research and Development category.
What is the CFDA number associated with this opportunity?
The CFDA number listed for this opportunity is 12.420.
Who is eligible to apply?
Eligibility is listed as unrestricted, meaning the competition is open to a broad range of applicant organizations, subject to any additional eligibility details that may appear in the full funding announcement.
When was the opportunity posted and what was the original closing date?
The opportunity was posted on June 15, 2021, and the original closing date was November 12, 2021.
How many awards were anticipated?
The opportunity anticipated making about four awards.
Is there a maximum award amount (award ceiling)?
The listed award ceiling is shown as 0 in the source data. This typically indicates that the maximum budget may be defined elsewhere in the full funding announcement or determined through programmatic and budget negotiation rather than a single fixed cap.
What is the overall "path" this award is trying to support?
The mechanism is positioned as a launchpad: fund an early, clinically relevant, hypothesis-driven study; generate convincing evidence and correlative or mechanistic insight; and use those results to support later, larger trials that can ultimately change clinical practice in chronic pain management.
What should applicants emphasize to align with the program's intent?
Applicants should emphasize clinical relevance, a clear and testable hypothesis, an innovative approach (including justified repurposing where appropriate), a well-defined clinical knowledge gap, and a credible plan for how the results will build a strong rationale for larger clinical trials and future practice-changing steps.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: National Sheriffs’ Institute (NSI) Executive Leadership Series
Previous opportunity: Rural Behavioral Health Workforce Centers – Northern Border Region
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for W81XWH 21 CPMRP CEA
Applicants also applied for:
Applicants who have applied for this opportunity (W81XWH 21 CPMRP CEA) also looked into and applied for these:
| Funding Opportunity |
|---|
| DOD Chronic Pain Management, Investigator-Initiated Research Award Apply for W81XWH 21 CPMRP IIRA Funding Number: W81XWH 21 CPMRP IIRA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DOD Chronic Pain Management, Translational Research Award Apply for W81XWH 21 CPMRP TRA Funding Number: W81XWH 21 CPMRP TRA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Promoting U.S. Values and Global Science Leadership Apply for SFOP0008209 Funding Number: SFOP0008209 Agency: Department of State, Bureau of Oceans - Int. Environmental - Scientific Category: Science and Technology and other Research and Development Funding Amount: $648,750 |
| DOD Alcohol and Substance Abuse Disorders Consortium Award Apply for W81XWH 21 ASADRP CA Funding Number: W81XWH 21 ASADRP CA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| NIJ FY 2021 Invited to Apply - Adolescent Brain Cognitive Development: Social Development Sub-study (ABCD: SD) Apply for O NIJ 2021 41002 Funding Number: O NIJ 2021 41002 Agency: Department of Justice, National Institute of Justice Category: Science and Technology and other Research and Development Funding Amount: $2,000,000 |
| NIJ FY 2021 Invited to Apply - Operation of the Secretariat of SC 37 under JTC 1 of ISO/IEC Apply for O NIJ 2021 41004 Funding Number: O NIJ 2021 41004 Agency: Department of Justice, National Institute of Justice Category: Science and Technology and other Research and Development Funding Amount: $50,000 |
| NIJ FY 2021 Invitation to Apply - American Association for the Advancement of Science (AAAS) Science & Technology Policy Fellows (STPF) Apply for O NIJ 2021 41003 Funding Number: O NIJ 2021 41003 Agency: Department of Justice, National Institute of Justice Category: Science and Technology and other Research and Development Funding Amount: $150,000 |
| Assessing the Role of Risk Science and Risk Transfer in Engineering With Nature® (EWN) Solutions and Advancing Research to Address Gaps and Opportunities Apply for W81EWF 21 SOI 0022 Funding Number: W81EWF 21 SOI 0022 Agency: Department of Defense, Engineer Research and Development Center Category: Science and Technology and other Research and Development Funding Amount: $200,000 |
| Fiscal Year (FY) 2021 Department of Defense Hypersonic Materials Manufacturing Initiative Apply for FOA AFRL AFOSR 2021 0010 Funding Number: FOA AFRL AFOSR 2021 0010 Agency: Department of Defense, Air Force Office of Scientific Research Category: Science and Technology and other Research and Development Funding Amount: $1,500,000 |
| Tribal Protocols Guidebook DoD Apply for W9126G 21 2 SOI 4607 Funding Number: W9126G 21 2 SOI 4607 Agency: Department of Defense, Fort Worth District Category: Science and Technology and other Research and Development Funding Amount: $125,000 |
| Fort Polk Conservation Support Apply for W9126G 21 2 SOI 4633 Funding Number: W9126G 21 2 SOI 4633 Agency: Department of Defense, Fort Worth District Category: Science and Technology and other Research and Development Funding Amount: $1,445,695 |
| Evaluating Mineral Associated Blue Carbon Accumulation in Coastal Wetlands Apply for W81EWF 21 SOI 0021 Funding Number: W81EWF 21 SOI 0021 Agency: Department of Defense, Engineer Research and Development Center Category: Science and Technology and other Research and Development Funding Amount: $140,000 |
| EVALUATION OF NEW HERBICIDE ALTERNATIVES INVASIVE PLANTS for IMPROVED & UNIMPROVED LANDS ON AIR FORCE BASES IN FL Apply for W9126G 21 2 SOI 4524 Funding Number: W9126G 21 2 SOI 4524 Agency: Department of Defense, Fort Worth District Category: Science and Technology and other Research and Development Funding Amount: $321,555 |
| GERMINATION: Germination of Research Questions for Addressing Critical Societal Challenges Apply for 21 594 Funding Number: 21 594 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Tribal Colleges and Universities Program Apply for 21 595 Funding Number: 21 595 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $3,500,000 |
| Cultural Resources Support AFCEC/CZ Apply for W9126G 21 2 SOI 4655 Funding Number: W9126G 21 2 SOI 4655 Agency: Department of Defense, Fort Worth District Category: Science and Technology and other Research and Development Funding Amount: $1,913,372 |
| Cultural Resources Support – Professional Archaeologist and Project Liaison for Solar EUL Development Project Oversight at Edwards AFB, CA Apply for W9126G 21 2 SOI 4579 Funding Number: W9126G 21 2 SOI 4579 Agency: Department of Defense, Fort Worth District Category: Science and Technology and other Research and Development Funding Amount: $415,000 |
| Understanding Thermal Mixing, Water Quality, and Algae Dynamics with the Pulsing of Releases from Jordan Reservoir in the Cape Fear River Apply for W9126G 21 2 SOI 4740 Funding Number: W9126G 21 2 SOI 4740 Agency: Department of Defense, Fort Worth District Category: Science and Technology and other Research and Development Funding Amount: $210,000 |
| Environmental DNA Sampling in the Lower Roanoke River Apply for W9126G 21 2 SOI 4742 Funding Number: W9126G 21 2 SOI 4742 Agency: Department of Defense, Fort Worth District Category: Science and Technology and other Research and Development Funding Amount: $335,000 |
| Ecosystem Function Model Analysis on the Roanoke River Apply for W9126G 21 2 SOI 4749 Funding Number: W9126G 21 2 SOI 4749 Agency: Department of Defense, Fort Worth District Category: Science and Technology and other Research and Development Funding Amount: $160,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 21 CPMRP CEA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.